Biological Information
Background Information:
The PathHunter® Pertuzumab Bioassay kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay assesses heregulin-β2-induced dimerization of ErbB2 and ErbB3 receptors. This product uses EFC technology. The included cells overexpress ErbB2 target protein fused to PK alongside ErbB3 target protein fused to EA. Upon ligand-induced dimerization of ErbB2 and ErbB3, detectable EFC signal is produced. This assay has been optimized and qualified with Perjeta (not supplied in the bioassay kit). Perjeta is a registered trademark of Genentech, Inc. Bioassay kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, control agonist, detection reagent, and assay plates.
Please reach out to Tech Support at DiscoverXSupportUS@discovery.eurofinsus.com for lot specific CoA.
Target Class:
Kinase
Family:
RTK
Sub Family:
Protein Tyrosine
Protein Name:
HER2
Protein Aliases:
neuro/glioblastoma derived oncogene homolog|human epidermal growth factor receptor 2
Accession Number:
NM_004448.2
UniProt Number:
P04626
Gene Name:
ERBB2
Gene ID:
2064
Gene Aliases:
NEU|HER-2|CD340|HER2
Target Species:
Human
Cell Background:
U2OS
Usage
Product Type:
Bioassay Kits
Application:
Potency, Commercial Release & Stability
Kit Components:
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Cell Based, Qualified
Assay Measures:
Dimerization
Detection Method:
Chemiluminescence
Bioassay Data
INN Drug Name:
Pertuzumab
Qualified With:
Perjeta®
Trademark Statement:
Perjeta® is a registered trademark of Genentech, Inc.
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
PathHunter®